Gastroenterology Doctors in Monterey, CA Accepting Medicare

11 Gastroenterology doctors found. Showing 1 - 11

Jan Kamler, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr Ste 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Richard Walter Hell, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Michael R Smith, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Toby J Katz, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. James A Di Sario, M.D. Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Isabelle Barnard Moonan, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Steve Hu, Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr Ste 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Kathryn A Swanson, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-3577

Dr. Daniel Gregory Luba, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Mary L Garren, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

Dr. Lloyd R Garren, M.D. Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 23 Upper Ragsdale Dr, Suite 200, Monterey, CA 93940 Phone: 831-375-3577    Fax: 831-375-1478

News Archive

Despite new constitution, much work remains to bring reproductive health care to all Kenyans

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, editor Amie Newman, a communications officer at the foundation, notes that in 2007, "Kenya enacted a new constitution which ... declares reproductive health care the right of all citizens," and writes, "Kenya's climb towards broad contraceptive coverage, and with that the hope for increased empowerment for women and girls and an improved economic situation for all, seems steep but scalable."

Scientists report latest research on sleep disorders at SFSS meeting

Sleep disorders are common among bus and tram drivers in Gothenburg: a quarter say that they have problems with daytime sleepiness, which could affect safety. Such are the results of a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden, presented at the annual Swedish Sleep Medicine Congress in Gothenburg on 21-23 April.

First implantation of WiCS wireless cardiac pacing system performed in Germany

EBR Systems, Inc., a privately held clinical stage company, announced today the first human implants of the WiCS Wireless Cardiac Stimulation System.

Merck's initiation of IMO-2055 Phase 1b clinical trial in SCCHN triggers €3.0M milestone payment to Idera

Idera Pharmaceuticals, Inc., today announced that it has achieved a milestone under its worldwide licensing and collaboration agreement with Merck KGaA, Darmstadt, Germany. The milestone was achieved upon Merck KGaA's initiation of a Phase 1b clinical trial of IMO-2055 (EMD 1201081), an agonist of Toll-like Receptor 9 (TLR9), in combination with cisplatin, fluorouracil and cetuximab (Erbitux®) in first-line treatment of patients with squamous cell carcinoma of the head and neck (SCCHN).

Lilly, Boehringer Ingelheim announce FDA acceptance of NDA filing for new insulin glargine product

Eli Lilly and Company and Boehringer Ingelheim today announced that the U.S. Food and Drug Administration has accepted the filing of the New Drug Application for LY2963016, an investigational basal (long-acting) insulin.

Read more Medical News

› Verified 6 days ago